Crossmark

Targeted RNA Sequencing of Head and Neck Adenoid Cystic Carcinoma Reveals SEC16A::NOTCH1 Fusion and MET Exon 14 Skipping as Potentially Actionable Alterations

Crossref DOI link: https://doi.org/10.1007/s12105-024-01694-7

Published Online: 2024-11-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chu, Ying-Hsia

Xu, Bin

Sukhadia, Purvil

Mohanty, Abhinita S.

DiNapoli, Sara E.

Ho, Alan L.

Katabi, Nora

Dogan, Snjezana
Funding

Funding for this research was provided by:

National Institutes of Health (P30 CA008748)
License Information

Text and Data Mining valid from 2024-11-07

Version of Record valid from 2024-11-07
More Information

Article History

Received: 7 August 2024

Accepted: 22 August 2024

First Online: 7 November 2024

Declarations

:

: Consent for publication was obtained for every individual person’s data included in the study.

: The authors declare no competing interests.

: The study is approved by the Institutional Review Board at the Memorial Sloan Kettering Cancer Center.

: Informed consent was obtained from all individual participants included in the study.

Document is current

Any future updates will be listed below